Ilex Medical Stock Fundamentals

ILX Stock   7,859  156.00  2.03%   
Ilex Medical fundamentals help investors to digest information that contributes to Ilex Medical's financial success or failures. It also enables traders to predict the movement of Ilex Stock. The fundamental analysis module provides a way to measure Ilex Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ilex Medical stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Ilex Medical Company Profit Margin Analysis

Ilex Medical's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profit Margin

 = 

Net Income

Revenue

X

100

More About Profit Margin | All Equity Analysis

Current Ilex Medical Profit Margin

    
  0.12 %  
Most of Ilex Medical's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ilex Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Based on the latest financial disclosure, Ilex Medical has a Profit Margin of 0.1194%. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The profit margin for all Israel stocks is notably lower than that of the firm.

Ilex Medical Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ilex Medical's current stock value. Our valuation model uses many indicators to compare Ilex Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ilex Medical competition to find correlations between indicators driving Ilex Medical's intrinsic value. More Info.
Ilex Medical is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about  0.61  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Ilex Medical is roughly  1.65 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Ilex Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Ilex Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Ilex Profit Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ilex Medical's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ilex Medical could also be used in its relative valuation, which is a method of valuing Ilex Medical by comparing valuation metrics of similar companies.
Ilex Medical is currently under evaluation in profit margin category among its peers.

Ilex Fundamentals

About Ilex Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Ilex Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ilex Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ilex Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Ilex Medical Ltd engages in marketing, selling, and supporting equipment, disposables, and reagents for laboratories and healthcare establishments in Israel and South Africa. Ilex Medical Ltd was founded in 1977 and is based in Petah Tikva, Israel. Ilex Medical is traded on Tel Aviv Stock Exchange in Israel.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Ilex Stock

Ilex Medical financial ratios help investors to determine whether Ilex Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ilex with respect to the benefits of owning Ilex Medical security.